New imaging tool helps surgeons pinpoint hidden parathyroid tumors
NCT ID NCT07218224
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This expanded access program offers patients with primary hyperparathyroidism a special PET scan using a radioactive tracer called 18F-fluorocholine. The scan helps doctors locate parathyroid adenomas—small, benign tumors that cause high calcium levels. By finding these tumors more accurately, surgeons can remove them more effectively. The program is available to patients aged 13 and older who meet eligibility criteria.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-fluorocholine (FCH)
What this could lead to
If successful, this imaging technique could help doctors precisely locate parathyroid adenomas, guiding surgery and improving outcomes.
What could go wrong
This is an expanded access program, not a formal trial, so evidence is limited. The imaging may not detect all adenomas, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARATHYROID ADENOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••